John C. Reed

EVP, Innovative Medicine, R&D

EVP, Innovative Medicine, R&D at JOHNSON & JOHNSON, filing insider transactions on 2026-02-17.

Total Purchases

—

0 transactions

Total Sales

$13.1M

3 transactions

Companies Traded

1

3 total filings

Active Since

2026-02-17

Last: 2026-02-17

Companies

JOHNSON & JOHNSON

Other Reporting Insiders at Johnson & Johnson

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-17	JNJ	Sale	21.7K	$243.00	$5.3M	12.9K	SEC ↗
2026-02-17	JNJ	Sale	2,283	$243.00	$555K	10.7K	SEC ↗
2026-02-17	JNJ	Sale	29.9K	$243.00	$7.3M	12.9K

John C. Reed (Johnson & Johnson) Insider Trades | Tormere